Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: The early markers for autism study

Translational Psychiatry

Volumn 6, Issue 4, 2016, Pages

  Zerbo, O ^a   Traglia, M ^b   Yoshida, C ^a   Heuer, L S ^c   Ashwood, P ^c,d   Delorenze, G N ^a   Hansen, R L ^c,e   Kharrazi, M ^f   Van De Water, J ^c,g   Yolken, R H ^h   Weiss, L A ^b   Croen, L A ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; AUTISM; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MOTHER; PREGNANCY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; AUTISM SPECTRUM DISORDER; CALIFORNIA; INFANT; MALE; RISK; SECOND TRIMESTER PREGNANCY;

ADULT; AUTISM SPECTRUM DISORDER; C-REACTIVE PROTEIN; CALIFORNIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT; MALE; MOTHERS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RISK; YOUNG ADULT;

EID: 85011303982     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.46     Document Type: Article

References (45)

1. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63-77.
2. Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977; 18: 297-321.
3. Geschwind DH. Autism: many genes, common pathways? Cell 2008; 135: 391-395.
4. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 1989; 30: 405-416.
5. Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 2006; 114: 1119-1125.
6. Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB. Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology 2014; 25: 44-47.
7. Colvert E, Tick B, McEwen F, Stewart C, Curran SR, Woodhouse E et al. Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry 2015; 72: 415-423.
8. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB et al. Most genetic risk for autism resides with common variation. Nat Genet 2014; 46: 881-885.
9. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011; 68: 1095-1102.
10. Atladottir HO, Henriksen TB, Schendel DE, Parner ET. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 2012; 130: e1447-e1454.
11. Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010; 40: 1423-1430.
12. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971; 1: 33-47.
13. Lee BK, Magnusson C, Gardner RM, Blomstrom S, Newschaffer CJ, Burstyn I et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav Immun 2014; 44: 100-105.
14. Zerbo O, Iosif AM, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord 2013; 43: 25-33.
15. Zerbo O, Qian Y, Yoshida C, Grether JK, Van de Water J, Croen LA. Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord 2013; 45: 4015-4025.
16. Bauman MD, Iosif AM, Smith SE, Bregere C, Amaral DG, Patterson PH. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatry 2014; 75: 332-341.
17. Patterson PH. Maternal infection and autism. Brain Behav Immun 2012; 26: 393.
18. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27: 10695-10702.
19. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
20. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R et al. Increased mid-gestational IFN-gamma, IL-4, and IL-5 in women giving birth to a child with autism: a case-control study. Mol Autism 2011; 2: 13.
21. Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 2007; 50: 1115-1122.
22. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C et al. Meta-analysis of genome-wide association studies in 480 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011; 123: 731-738.
23. Okada Y, Takahashi A, Ohmiya H, Kumasaka N, Kamatani Y, Hosono N et al. Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet 2011; 20: 1224-1231.
24. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008; 82: 1185-1192.
25. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009; 302: 37-48.
26. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T et al. Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 2011; 342: d548.
27. Ernst GD, de Jonge LL, Hofman A, Lindemans J, Russcher H, Steegers EA et al. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study. Am J Obstet Gynecol 2011; 205: 132.e1-132.e12.
28. Grgic G, Skokic F, Bogdanovic G. C-reactive protein as a biochemical marker of idiopathic preterm delivery. Med Arh 2010; 64: 132-134.
29. Hwang HS, Kwon JY, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2007; 98: 105-109.
30. Lohsoonthorn V, Qiu C, Williams MA. Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clin Biochem 2007; 40: 330-335.
31. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59: 29-37.
32. Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 2014; 19: 259-264.
33. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003; 289: 49-55.
34. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord 2013; 150: 456-459.
35. Grether JK, Croen LA, Anderson MC, Nelson KB, Yolken RH. Neonatally measured immunoglobulins and risk of autism. Autism Res 2010; 3: 323-332.
36. Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard-Pedersen B, Hougaard DM et al. Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study. Cytokine 2013; 61: 370-376.
37. Tsang KM, Croen LA, Torres AR, Kharrazi M, Delorenze GN, Windham GC et al. A genome-wide survey of transgenerational genetic effects in autism. PLoS One 2013; 8: e76978.
38. Hoffmann TJ, Kvale MN, Hesselson SE, Zhan Y, Aquino C, Cao Y et al. Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics 2011; 98: 79-89.
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
40. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76-82.
41. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073.
42. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336-2337.
43. Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123: 46-51.
44. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004; 19: 1025-1030.
45. Watts DH, Krohn MA, Wener MH, Eschenbach DA. C-reactive protein in normal pregnancy. Obstet Gynecol 1991; 77: 176-180.